TMCnet News

BUYINS.NET: Market Maker Surveillance Report. HBIO, CPSS, TSTC, INFI, OCZ, JKS, Losing Stocks With Lowest Price Friction For Wednesday, April 10th 2013
[April 11, 2013]

BUYINS.NET: Market Maker Surveillance Report. HBIO, CPSS, TSTC, INFI, OCZ, JKS, Losing Stocks With Lowest Price Friction For Wednesday, April 10th 2013


(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3634 companies with "abnormal" market making, 4076 companies with positive Friction Factors and 1692 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Harvard Bioscience Inc (NASDAQ:HBIO), Consumer Portfolio Services Inc (NASDAQ:CPSS), Telestone Technologies Corp (NASDAQ:TSTC), Infinity Pharmaceuticals Inc (NASDAQ:INFI), OCZ Technology Group Inc (NASDAQ:OCZ), Jinkosolar Holding Co Ltd (NYSE:JKS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .



Market Maker Friction Factor is shown in the chart below: Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction HBIO $-0.760 -13.57% 335,801 38.17% 543,840 61.82% -208,039 -2,737 CPSS $-0.960 -8.92% 200,601 41.79% 274,220 57.13% -73,619 -767 TSTC $-0.180 -14.40% 111,770 34.22% 209,852 64.25% -98,082 -5,449 INFI $-4.190 -8.98% 1,095,014 49.00% 1,127,468 50.45% -32,454 -77 OCZ $-0.150 -9.09% 889,482 35.12% 1,642,911 64.88% -753,429 -50,229 JKS $-0.520 -8.97% 380,388 30.59% 484,761 38.98% -104,373 -2,007 Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows HBIO with a dollar loss Wednesday of $-0.76000 and a Friction Factor of -2,737 shares. That means that it only took 2,737 more shares of selling than buying to move HBIO lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.


Harvard Bioscience Inc (NASDAQ:HBIO) - Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities, and government laboratories worldwide. The company s products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company s molecular biology products consist of molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, amino acid analysis systems, liquid dispensers, and gel electrophoresis systems, as well as liquid handling consumables primarily pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes various devices, instruments, and consumable items used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products for in vivo sampling and monitoring of organs and tissues, and behavioral measurement products focusing on systems for assessing learning and memory utilized in research laboratories. The company sells its products through catalog, Website, distributors, and direct sales force. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts..

Consumer Portfolio Services Inc (NASDAQ:CPSS) - Consumer Portfolio Services, Inc., a specialty finance company, engages in purchasing and servicing retail automobile contracts originated by franchised automobile dealers and select independent dealers in the sale of new and used automobiles, light trucks, and passenger vans in the United States. The company, through its automobile contract purchases, provides indirect financing to the customers of dealers with limited credit histories, low incomes, or past credit problems. It serves as an alternative source of financing for dealers, facilitating sales to customers who might not be able to obtain financing. The company also purchases vehicle purchase money loans from non-affiliated lenders; and directly originates vehicle purchase money loans by lending money directly to consumers. Consumer Portfolio Services, Inc. provides its automobile contracts through its headquarters and three servicing branches in Virginia, Florida, and Illinois. The company was founded in 1991 and is headquartered in Irvine, California..

Telestone Technologies Corp (NASDAQ:TSTC) - Telestone Technologies Corporation offers wireless local-access network technologies and solutions primarily in the People s Republic of China. It designs, engineers, and sells radio frequency (RF) based local-access network solutions for indoor and outdoor wireless coverage, IP-based products for Internet access, and unified local-access network solutions based on its Wireless and Fiber-Optics Distribution System technology. The company provides electronic equipments, such as wireless fiber-optic distribution system products, RFPA products, passive components, repeaters, radio frequency peripherals, and base station antennas used to provide access network solutions for 2G, 3G, broadband access, and CATV networks. It also offers project design, project management, installation, maintenance, and other after-sales services. The company provides its solutions to the telecommunications industry for use in indoor and outdoor environments, including hotels, residential estates, office buildings, airports, exhibition centers, underground stations, highways, and tunnels. Telestone Technologies Corporation was founded in 1987 and is headquartered in Beijing, the People's Republic of China..

Infinity Pharmaceuticals Inc (NASDAQ:INFI) - Infinity Pharmaceuticals, Inc., a drug discovery and development company, focuses on discovering, developing, and delivering medicines to patients for diseases with significant unmet need. Its lead product candidates include IPI-145 and IPI-443, inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K); and Retaspimycin HCl, a heat shock protein 90 inhibitor. The company is pursuing a dual development path for IPI-145 in both hematologic malignancies and inflammation. IPI-145 is in an ongoing Phase I dose-escalation trial in patients with advanced hematologic malignancies and in a Phase II study in patients with mild, allergic asthma. In addition, the company plans to initiate a Phase IIa signal-finding study in patients with rheumatoid arthritis. IPI-443 is undergoing preclinical studies to enable Phase I development. Retaspimycin HCl is in a Phase II trial in combination with docetaxel to treat patients with non-small cell lung cancer (NSCLC) and in an exploratory Phase Ib/II trial in combination with everolimus in NSCLC patients with a KRAS mutation. The company is headquartered in Cambridge, Massachusetts..

OCZ Technology Group Inc (NASDAQ:OCZ) - OCZ Technology Group, Inc. engages in the design, manufacture, and distribution of solid state drives (SSDs) and computer components primarily in the United States, Canada, Germany, the Middle East, Africa, and other European countries. It specializes in high-speed memory in the enterprise and consumer SSD markets, a technology that competes with traditional rotating magnetic hard disk drives. The company provides SSDs, including MLC-based drives, SLC-based drives, and portable SSD and USB drives for personal computers, servers, data storage systems, and industrial equipments. It also offers various components for computing devices and systems, including AC/DC switching power supplies, as well as computer gaming solutions; and memory processing products. The company sells its products directly to enterprise customers and original equipment manufacturers through its direct sales force; and to other end customers through a channel of systems integrators, information technology, integrators, and fulfillment and retail distributors. OCZ Technology Group, Inc. was founded in 2002 and is headquartered in San Jose, California..

Jinkosolar Holding Co Ltd (NYSE:JKS) - JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in designing, developing, producing, and marketing photovoltaic products in the People s Republic of China and internationally. It offers solar modules; solar cells; mono and multi crystalline silicon ingots and silicon wafers; recovered silicon materials; solar power project development and solar system integration services; and processing services. The company sells its solar modules to distributors, project developers, system integrators, and other players in the solar power industry under the JinkoSolar brand, as well as on an original equipment manufacturer basis. JinkoSolar Holding Co., Ltd. has a strategic cooperation agreement with Jinchuan Group co.,ltd. to invest and develop a 200 MW photovoltaic solar power plant in Jinchang, Gansu Province. The company was founded in 2006 and is based in Shangrao, the People s Republic of China..

About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 [email protected] www.buyins.net CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to [email protected])).

(c) 2013 M2 COMMUNICATIONS

[ Back To TMCnet.com's Homepage ]